IFNG and neoplasm: The antitumor immune response is shaped by a complex interplay within the tumor microenvironment, encompassing TILs (tumor-infiltrating lymphocytes), PD-L1 (Programmed Death-Ligand 1) expression, mutational burden, neoantigen presentation, and an IFN-γ(interferon-γ) gene signature (1–4).